Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Start-Up Quarterly Statistics, Q4 2012

Feb 05 2013

• By Deanna Kamienski

Related Content

Ziarco Picks Up Pfizer Assets, Series A Round

Nov 05 2012

Vicept Management, VCs Team Up Again To Launch Aclaris With $21M

Oct 26 2012

Roche Enters Hearing-Loss Space In Risk-Sharing Venture With Inception, Versant

Oct 11 2012

Ultragenyx Raises $75 Million Series B, Prepares For A 2014 IPO

Dec 20 2012

Moderna To Focus On Messenger RNA Approaches To Recreate Therapeutic Proteins

Dec 06 2012

Everyone Wins In Deal Between BMS And The Medicines Co.

Dec 12 2012

NeRRe Therapeutics Spun Out Of GSK’s Unwanted Neuroscience Assets

Dec 21 2012

Related Companies

Ziarco Pharma Ltd

Pfizer Inc.

NeRRe Therapeutics, Ltd.

GSK plc

Aclaris Therapeutics, Inc.

Bicycle Therapeutics, plc

Galera Therapeutics, Inc.

Neurovance, Inc.

Thesan Pharmaceuticals, Inc.

Nuron Biotech, Inc.

Inception 3, Inc.

Inception Sciences

Stanford University

Roche Holding AG

Amgen, Inc.

Atara Biotherapeutics, Inc.

Ultragenyx Pharmaceutical Inc.

Moderna, Inc.

Harvard University

LoneStar Heart, Inc.

Cibiem Inc.

Innovative Trauma Care

Atossa Therapeutics, Inc.

Chiromics LLC

Bristol Myers Squibb Company

Princeton University

Roche Holding AG

Titan Pharmaceuticals Inc.

Apple Tree Partners

Sorin Group

HighLife SAS

The Medicines Company

Linepharma

Johnson & Johnson

Paladin Pharma Inc.

Endo, Inc.

3M

3M

Additional Topics

Deals BioPharmaceutical Medical Device

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window